The acetylation polymorphism is one of the most common inherited varia
tions in the biotransformation of drugs and chemicals. Its association
with drug toxicity and increased risk of developing certain diseases
and certain types of chemically induced cancers has made it one of the
oldest and best studied examples of pharmacogenetic conditions. N-Ace
tylation of sulfamethazine was studied in 74 unrelated healthy Iranian
volunteers. The frequency of slow acetylators, determined by using fr
ee and total plasma sulfamethazine concentrations, was 78.4%. The mean
acetylation ratio was 19.48% for slow acetylators, and the frequency
of the recessive allele controlling slow acetylation was found to be 0
.88. This percentage is similar to that observed in various Arab count
ries and higher than that observed in Europeans.